
We are going to make it normal for people with a new diagnosis of cancer to understand their disease and the appropriate treatment before they even meet their oncologist.
✓Radiation Oncologist. I help clinical trial sponsors convert protocols into scalable video assets • Building leverage around patient education at @primr_med

We are going to make it normal for people with a new diagnosis of cancer to understand their disease and the appropriate treatment before they even meet their oncologist.

Can ctDNA help us detect molecular residual disease and guide personalized treatment in patients with high-risk TNBC? Our @TheTBCRC PREDICT-RD trial is investigating MRD-guided treatment with datopotamab deruxtecan (Dato-DXd) in patients with persistent ctDNA after neoadjuvant therapy and surgery. Now open at @UNC_Lineberger and @ONealCancerUAB Opening soon at @UChicago, @MontefioreNYC @MayoCancerCare & @DukeCancer Thank you @PRIMR_MED for highlighting our study and helping raise awareness! 🎥 Watch below! #bcsm

Huge milestone as @Clarity_Pharma hits target enrollment for the CLARIFY trial! 🎉 Clearer imaging brings real hope for better #prostatecancer care. Proud PRIMR supported this with patient education!

Huge milestone as the ARCHER study hits 100 patients! 🎉 It’s evaluating if 5 sessions of high-dose SBRT can shorten radiation and preserve the bladder in MIBC. Proud to share the explainer video we created to help explain the trial below! primrmed.com/cancer-clinical…

Watch the patient education video below for clear, practical information on rectal spacers and fiducial markers, and what patients may expect before prostate radiation. 👇 primrmed.com/cancer-educatio…

Proud of what we're building at PRIMR. Shout out to friends and collaborators @HimanshuNagarMD, @drthomaskole, @MSK_RadOnc, as well as the #patientadvocates who contributed to production of this content. Read the full blog: primrmed.com/blog-post/recta…

Patients arrive to clinic already informed. Nurses and MDs spend less time re-explaining and more time on what actually needs a human in the room. Whether it's a procedure, a clinical trial, or a new drug or treatment, this is what scalable patient education should look like.

PRIMR exists to break down complex cancer treatment into something patients can actually understand, on their own time, at their own pace. The secondary effect is just as valuable: this content pre-loads education before a procedure and gives clinical teams async bandwidth back.

Knowledge transfer collapsed. Retention cratered. Not because clinicians explained things worse, but because isolation and fear make it nearly impossible to absorb anything. That's the problem @PRIMR_MED was built to solve.

COVID showed how easily patient education can break down. No-visitor policies meant patients faced complex cancer treatment decisions alone, no family in the room, no one to help them process what they'd just heard.

🚨 @MSK_RadOnc is recruiting TWO faculty radiation oncologists for our New Jersey sites! 🔬 Clinical or clinical-research tracks ⏳ 20–40% protected research time 🏥 Join a collaborative, academically focused team at @MSKCancerCenter Email @seanmmcbride or @simonpowell213 if interested in applying.

🎉 Congrats to @NRGonc & PIs @ndesai2005 and @aleberlin2 on hitting accrual target for NRG-GU010 (GUIDANCE)! Thank you both for partnering with us to create the 3-part video series—trusting PRIMR to produce patient-centric educational content. #ProstateCancer #ClinicalTrials

PRIMR provides the clarity sponsors need to enhance patient and site engagement throughout clinical trials. 💡🏥 primrmed.com/ #cancer #clinicaltrials #clinicalresearch #patienteducation #prostatecancer

#PRIMR turns trials into engaging visual stories. The RadiCaL Study is testing whether adding Radium-223 to treatment can target kidney cancer that has spread to bones and reduce pain. Watch: primrmed.com/cancer-clinical… @DrRanaMcKay @ALLIANCE_org

New blog! 📢 Ever wonder how to target cancer precisely and spare healthy tissue when chemo fails? In this blog, we discover what antibody-drug conjugates (ADCs) are, how they work, and why they're a game-changer in precision oncology. primrmed.com/blog-post/what-…

Boost trial enrollment with PRIMR’s clear video resources. Empower patients with simple, trusted info for confident participation. 📊💡 primrmed.com/ #cancer #clinicaltrials #clinicalresearch #patienteducation #lungcancer